William Tamborlane
Pediatric Endocrinology · New Haven, CTNPI 1124001342
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $146,105 of the $181,841 with a category attached, or 80.3%. 12 manufacturers reported payments, led by Boehringer Ingelheim at 56.8% of the total. Reporting peaked in 2019 at $69,044 and has fallen 98.8% since, to $857 in 2024. Among pediatric endocrinology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $1998.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$103K
- Medtronic$32K
- Novo Nordisk$14K
- Novo Nordisk AS$11K
- Ipsen Bioscience Inc.$9K
- Boehringer Ingelheim International GmbH$6K
- plus $7K from 6 others
Across 293 payments — averaging $3197.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$239K
- Takeda Pharmaceuticals U.S.A., Inc.$200K
- Novo Nordisk$189K
- Astrazeneca UK Limited$137K
- Boehringer Ingelheim Pharma GmbH & Co.kg$63K
- Sanofi US Services Inc.$59K
- plus $51K from 3 others
What the payments were for
- Consulting fees$146,10580%
- Speaking & faculty fees$29,09316%
- Travel & lodging$5,0293%
- Food & beverage$1,6141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 26 | $103,276 |
| Medtronic(2 entities) | 27 | $31,924 |
| Novo Nordisk | 15 | $14,383 |
| Novo Nordisk AS | 3 | $10,813 |
| Ipsen Bioscience Inc. | 1 | $9,000 |
| Boehringer Ingelheim International GmbH | 10 | $5,943 |
| Eisai Inc. | 3 | $3,850 |
| Sanofi-aventis U.S. LLC | 1 | $2,340 |
| Companion Medical, Inc. | 2 | $140 |
| AstraZeneca | 1 | $132 |
| Lilly USA, LLC | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$181,841 in reported general payments places this provider in the 90th percentile of 31 pediatric endocrinology providers in Connecticut.
Other pediatric endocrinology in New Haven
- Sonia CaprioNew Haven$188K
- Jennifer SherrNew Haven$158K
- Thomas CarpenterNew Haven$93K
- Eda CengizNew Haven$68K
- Stuart WeinzimerNew Haven$41K
- Cemre RobinsonNew Haven$7K
- Michelle van NameNew Haven$2K
- Stephan SiebelNew Haven$369
- Apoorva Ravindranath WaikarNew Haven$294
- Jennifer SarhisNew Haven$103
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.